FDA approval: ceritinib for the treatment of metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer Clin. Cancer Res., 21 (11) (2015), pp. 2436-2439 View in ScopusGoogle Scholar [9] A.T. Shaw, T.M. Kim, L. Crinò, C. Gridelli, K. Kiura, G. Liu, S. Novello...